Trans-(−)-Kusunokinin: A Potential Anticancer Lignan Compound against HER2 in Breast Cancer Cell Lines?

Trans-(−)-kusunokinin, an anticancer compound, binds CSF1R with low affinity in breast cancer cells. Therefore, finding an additional possible target of trans-(−)-kusunokinin remains of importance for further development. Here, a computational study was completed followed by indirect proof of specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Rattanaburee, Thidarath, Tanawattanasuntorn, Tanotnon, Thongpanchang, Tienthong, Tipmanee, Varomyalin, Graidist, Potchanapond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348432/
https://www.ncbi.nlm.nih.gov/pubmed/34361688
http://dx.doi.org/10.3390/molecules26154537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348432/
https://www.ncbi.nlm.nih.gov/pubmed/34361688
http://dx.doi.org/10.3390/molecules26154537

Ejemplares similares